Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Hereditary Angioedema Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Hereditary Angioedema Drug market segmented into
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Based on the end-use, the global Hereditary Angioedema Drug market classified into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Based on geography, the global Hereditary Angioedema Drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HEREDITARY ANGIOEDEMA DRUG INDUSTRY
2.1 Summary about Hereditary Angioedema Drug Industry
2.2 Hereditary Angioedema Drug Market Trends
2.2.1 Hereditary Angioedema Drug Production & Consumption Trends
2.2.2 Hereditary Angioedema Drug Demand Structure Trends
2.3 Hereditary Angioedema Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 By Product
4.2.2 C1 Esterase Inhibitor
4.2.3 Kallikrein Inhibitor
4.2.4 Selective Bradykinin B2 Receptor Antagonist
4.2.5 By Route of Administration
4.2.6 Oral
4.2.7 Intravenous
4.2.8 Subcutaneous Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Retail Pharmacies
4.3.2 Hospital Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 By Product
5.2.2 C1 Esterase Inhibitor
5.2.3 Kallikrein Inhibitor
5.2.4 Selective Bradykinin B2 Receptor Antagonist
5.2.5 By Route of Administration
5.2.6 Oral
5.2.7 Intravenous
5.2.8 Subcutaneous Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Retail Pharmacies
5.3.2 Hospital Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 By Product
6.2.2 C1 Esterase Inhibitor
6.2.3 Kallikrein Inhibitor
6.2.4 Selective Bradykinin B2 Receptor Antagonist
6.2.5 By Route of Administration
6.2.6 Oral
6.2.7 Intravenous
6.2.8 Subcutaneous Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Retail Pharmacies
6.3.2 Hospital Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 By Product
7.2.2 C1 Esterase Inhibitor
7.2.3 Kallikrein Inhibitor
7.2.4 Selective Bradykinin B2 Receptor Antagonist
7.2.5 By Route of Administration
7.2.6 Oral
7.2.7 Intravenous
7.2.8 Subcutaneous Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Retail Pharmacies
7.3.2 Hospital Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 By Product
8.2.2 C1 Esterase Inhibitor
8.2.3 Kallikrein Inhibitor
8.2.4 Selective Bradykinin B2 Receptor Antagonist
8.2.5 By Route of Administration
8.2.6 Oral
8.2.7 Intravenous
8.2.8 Subcutaneous Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Retail Pharmacies
8.3.2 Hospital Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 By Product
9.2.2 C1 Esterase Inhibitor
9.2.3 Kallikrein Inhibitor
9.2.4 Selective Bradykinin B2 Receptor Antagonist
9.2.5 By Route of Administration
9.2.6 Oral
9.2.7 Intravenous
9.2.8 Subcutaneous Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Retail Pharmacies
9.3.2 Hospital Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pharming Group NV
10.1.2 Shire plc
10.1.3 CSL Limited
10.1.4 iBio Inc.
10.1.5 BioCryst Pharmaceuticals, Inc.
10.1.6 Ionis Pharmaceuticals, Inc.
10.2 Hereditary Angioedema Drug Sales Date of Major Players (2017-2020e)
10.2.1 Pharming Group NV
10.2.2 Shire plc
10.2.3 CSL Limited
10.2.4 iBio Inc.
10.2.5 BioCryst Pharmaceuticals, Inc.
10.2.6 Ionis Pharmaceuticals, Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Hereditary Angioedema Drug Product Type Overview
2.Table Hereditary Angioedema Drug Product Type Market Share List
3.Table Hereditary Angioedema Drug Product Type of Major Players
4.Table Brief Introduction of Pharming Group NV
5.Table Brief Introduction of Shire plc
6.Table Brief Introduction of CSL Limited
7.Table Brief Introduction of iBio Inc.
8.Table Brief Introduction of BioCryst Pharmaceuticals, Inc.
9.Table Brief Introduction of Ionis Pharmaceuticals, Inc.
10.Table Products & Services of Pharming Group NV
11.Table Products & Services of Shire plc
12.Table Products & Services of CSL Limited
13.Table Products & Services of iBio Inc.
14.Table Products & Services of BioCryst Pharmaceuticals, Inc.
15.Table Products & Services of Ionis Pharmaceuticals, Inc.
16.Table Market Distribution of Major Players
17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
19.Table Global Hereditary Angioedema Drug Market Forecast (Million USD) by Region 2021f-2026f
20.Table Global Hereditary Angioedema Drug Market Forecast (Million USD) Share by Region 2021f-2026f
21.Table Global Hereditary Angioedema Drug Market Forecast (Million USD) by Demand 2021f-2026f
22.Table Global Hereditary Angioedema Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Hereditary Angioedema Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Hereditary Angioedema Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Hereditary Angioedema Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Hereditary Angioedema Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Hereditary Angioedema Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Hereditary Angioedema Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Hereditary Angioedema Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure By Product Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure C1 Esterase Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Kallikrein Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Selective Bradykinin B2 Receptor Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure By Route of Administration Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Subcutaneous Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure By Product Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure C1 Esterase Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Kallikrein Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Selective Bradykinin B2 Receptor Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure By Route of Administration Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Subcutaneous Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure By Product Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure C1 Esterase Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Kallikrein Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Selective Bradykinin B2 Receptor Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure By Route of Administration Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Subcutaneous Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure By Product Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure C1 Esterase Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Kallikrein Inhibitor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Selective Bradykinin B2 Receptor Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure By Route of Administration Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Subcutaneous Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Online Pharmacies Segmentation Market Size (USD Mi